InvestSMART

Telix Pharmaceuticals Limited (ASX: TLX) - Announcements

Current share price for TLX : $16.690 0.19 (1.15%)+

ASX company news and announcements for Telix Pharmaceuticals Limited (TLX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Telix Pharmaceuticals Limited (TLX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Telix Pharmaceuticals Limited (TLX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Telix Pharmaceuticals Limited (TLX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5,671 Webcast link correction - JP Morgan Conference Presentation 10 Jan 2023 12:58PM $6.510 $16.690 risen by 156.37%
$5,671 Notification of cessation of securities - TLX 9 Jan 2023 8:26AM $7.400 $16.690 risen by 125.54%
$5,671 JP Morgan Healthcare Conference Presentation 9 Jan 2023 8:20AM $7.400 $16.690 risen by 125.54%
$5,671 JP Morgan Healthcare Conference and Trading Update 9 Jan 2023 8:20AM $7.400 $16.690 risen by 125.54%
$5,671 Cleansing Notice 30 Dec 2022 8:24AM $7.010 $16.690 risen by 138.09%
$5,671 Application for quotation of securities - TLX 30 Dec 2022 8:24AM $7.010 $16.690 risen by 138.09%
$5,671 ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GU 22 Dec 2022 8:25AM $6.880 $16.690 risen by 142.59%
$5,671 Cleansing Notice 19 Dec 2022 1:22PM $7.035 $16.690 risen by 137.24%
$5,671 Application for quotation of securities - TLX 19 Dec 2022 1:19PM $7.030 $16.690 risen by 137.41%
$5,671 App 3Y Change in Director Interests - T Olsen 15 Dec 2022 9:04AM $7.100 $16.690 risen by 135.07%
$5,671 Leadership Changes, including Company Secretary Appointment 5 Dec 2022 8:25AM $7.400 $16.690 risen by 125.54%
$5,671 Cleansing Notice 28 Nov 2022 8:21AM $7.370 $16.690 risen by 126.46%
$5,671 Application for quotation of securities - TLX 28 Nov 2022 8:21AM $7.370 $16.690 risen by 126.46%
$5,671 Release of shares from voluntary escrow 28 Nov 2022 8:20AM $7.370 $16.690 risen by 126.46%
$5,671 Telix Acquires Optimal Tracers 14 Nov 2022 8:25AM $6.780 $16.690 risen by 146.17%
$5,671 Appendix 3Y - Change of Directors Interest Notice 10 Nov 2022 8:13AM $6.880 $16.690 risen by 142.59%
$5,671 Cleansing Notice 10 Nov 2022 8:12AM $6.880 $16.690 risen by 142.59%
$5,671 Application for quotation of securities - TLX 10 Nov 2022 8:12AM $6.880 $16.690 risen by 142.59%
$5,671 Cleansing Notice 7 Nov 2022 9:10AM $6.910 $16.690 risen by 141.53%
$5,671 Notification regarding unquoted securities - TLX 7 Nov 2022 9:05AM $6.910 $16.690 risen by 141.53%
$5,671 Application for quotation of securities - TLX 7 Nov 2022 9:05AM $6.910 $16.690 risen by 141.53%
$5,671 ZIRCON Ph III Imaging Study - Top-Line data presentation 7 Nov 2022 8:22AM $6.910 $16.690 risen by 141.53%
$5,671 ZIRCON Ph III Imaging Study - Positive Top-Line Results 7 Nov 2022 8:22AM $6.910 $16.690 risen by 141.53%
$5,671 Notification regarding unquoted securities - TLX 26 Oct 2022 10:45AM $7.010 $16.690 risen by 138.09%
$5,671 Notification of cessation of securities - TLX 25 Oct 2022 10:45AM $7.000 $16.690 risen by 138.43%

451 - 475 of 953 results

Page 19 of 39

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.